Company profile
Mountain Valley MD Holdings Inc.
OTC: MVMDF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Concord, ONReports USD
#1099 of 1,418 Healthcare companies by revenue28th-percentile growth
EA Score
——FH —DQ —GM —SS 27
v0.1 · 5/100 weight · pillars only
↑ balance-sheet leverage, disclosure history · ↓ workforce scale, net margin
Methodology →Revenue TTM
$47.1k
Rev growth YoY (TTM)
+34.0%
Net income (FY)
-$5.4M
Employees
1
as of 2026-08-21
Market cap
$16.6M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$35.2k49.0k CAD2025
Net income-$5.4M-7.5M CAD2025
Operating income-$2.4M-3.4M CAD2025
Total assets$1.9M2.7M CAD2025
Liabilities$145.4k209.0k CAD2025
Equity$1.8M2.5M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Mountain Valley MD Holdings Inc.’s revenue?
Mountain Valley MD Holdings Inc. booked $35.2k in FY2025 revenue, contracting 21% year over year — slower than 72% of Healthcare companies we track, at a -15249.0% net margin.
Peers · Healthcare
Forte Biosciences, Inc.26DLyell Immunopharma, Inc.31DNanoLogix, Inc.——Cognetivity Neurosciences Ltd.——CuraScientific Corp——Impact BioMedical Inc.32DKey facts
CEODennis Hancock
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersConcord, ON
ExchangeOTC: MVMDF
Employees1
IPO date2020-05-19
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.